KRAS-regulated genes were identified by differential gene expression analysis of TCGA lung adenocarcinoma samples and lung adenocarcinoma cell lines from the CCLE, which were stratified as having high or low RAS pathway activity using a novel 84-gene RAS transcriptional metasignature derived from multiple RAS pathway signatures (30). This evidence concerns the gene KRAS and lung adenocarcinoma.